Microbot Medical Files 8-K: Regulation FD Disclosure & Exhibits
Ticker: MBOT · Form: 8-K · Filed: Mar 26, 2026 · CIK: 0000883975
| Field | Detail |
|---|---|
| Company | Microbot Medical Inc. (MBOT) |
| Form Type | 8-K |
| Filed Date | Mar 26, 2026 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: regulation-fd, disclosure, exhibit, corporate-action
TL;DR
**Microbot Medical just dropped an 8-K with new info, check Exhibit 99.1!**
AI Summary
Microbot Medical Inc. filed an 8-K on March 26, 2026, under Item 7.01, Regulation FD Disclosure, and Item 9.01, Financial Statements and Exhibits. This filing indicates the company is making a public disclosure of material non-public information, likely through a press release or investor presentation, which is included as Exhibit 99.1. For investors, this matters because it signals that new, potentially market-moving information about Microbot Medical Inc. (CIK: 0000883975) is being released, which could impact the stock price.
Why It Matters
This filing means Microbot Medical Inc. is publicly sharing important new information, which could influence investor perception and the company's stock value.
Risk Assessment
Risk Level: low — This 8-K is a procedural filing for disclosing information, not an event that inherently carries high risk.
Analyst Insight
A smart investor would immediately review Exhibit 99.1 to understand the specific material information being disclosed, as it could impact the company's valuation and future prospects.
Key Numbers
- 38233 — Size of 8-K form document (Indicates the size of the main 8-K document in bytes.)
- 19972 — Size of Exhibit 99.1 (Indicates the size of the key exhibit containing the disclosed information in bytes.)
- 229113 — Size of complete submission text file (Represents the total size of the entire filing submission in bytes.)
Key Players & Entities
- Microbot Medical Inc. (company) — the filer of the 8-K
- 0000883975 (company) — the CIK of Microbot Medical Inc.
- 2026-03-26 (date) — the filing date and period of report
- 943078125 (company) — the EIN of Microbot Medical Inc.
Forward-Looking Statements
- Microbot Medical Inc. will issue a press release or hold an investor call related to the information in Exhibit 99.1. (Microbot Medical Inc.) — high confidence, target: 2026-03-27
FAQ
What is the primary purpose of this 8-K filing by Microbot Medical Inc.?
The primary purpose of this 8-K filing by Microbot Medical Inc. is to disclose material non-public information under Item 7.01 (Regulation FD Disclosure) and to include related financial statements and exhibits under Item 9.01, specifically Exhibit 99.1.
When was this 8-K filing submitted and accepted by the SEC?
This 8-K filing was submitted and accepted by the SEC on March 26, 2026, with an acceptance time of 08:35:33.
What specific exhibit is included in this 8-K filing that likely contains the new information?
The specific exhibit included in this 8-K filing that likely contains the new information is EX-99.1, described as 'ex99-1.htm'.
What is Microbot Medical Inc.'s CIK number and state of incorporation?
Microbot Medical Inc.'s CIK number is 0000883975, and its state of incorporation is DE (Delaware).
What is the SIC code for Microbot Medical Inc. and what industry does it represent?
Microbot Medical Inc.'s SIC code is 3841, which represents 'Surgical & Medical Instruments & Apparatus'.
Filing Stats: 533 words · 2 min read · ~2 pages · Grade level 11.2 · Accepted 2026-03-26 08:35:33
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value MBOT NASDAQ Capital Mark
Filing Documents
- form8-k.htm (8-K) — 37KB
- ex99-1.htm (EX-99.1) — 20KB
- 0001493152-26-012812.txt ( ) — 224KB
- mbot-20260326.xsd (EX-101.SCH) — 3KB
- mbot-20260326_lab.xml (EX-101.LAB) — 33KB
- mbot-20260326_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. MICROBOT MEDICAL INC. By: /s/ Harel Gadot Name: Harel Gadot Title: Chief Executive Officer, President and Chairman Date: March 26, 2026